Core Viewpoint - China National Pharmaceutical Group announced that its subsidiary, Chengdu Tianqing, received approval for the CDK2/4/6 inhibitor, Kemosir Capsule (brand name: Saitanxin), for the treatment of HR+/HER2- locally advanced or metastatic breast cancer previously treated with endocrine therapy [1] Group 1: Product Development and Market Position - The company is expanding the indications for Kemosir, including first-line treatment for HR+/HER2- advanced breast cancer in combination with Fulvestrant and adjuvant therapy for HR+ early breast cancer [1] - The breast cancer treatment market is growing, becoming one of the most competitive areas for innovative drugs globally [1] - The company has established a comprehensive portfolio in the breast cancer field, covering various molecular subtypes such as HER2 positive (HER2+), low HER2 expression, HR positive (HR+/HER2-), and triple-negative breast cancer (TNBC) [1] Group 2: Comprehensive Treatment Coverage - The company systematically covers the entire treatment cycle for breast cancer, including adjuvant therapy, first-line, second-line, and neoadjuvant treatment scenarios, aiming to provide new treatment options for more patients [1] - In addition to Kemosir in the HR+/HER2- field, the company has differentiated products such as TQB2102 (HER2 dual antibody ADC), TQB3126 (ER-PROTAC), and TQB3202 (PI3Kα) [1] - The company has fully established a portfolio of mainstream foundational drugs for breast cancer, including already marketed products such as Qingkeyi (Fulvestrant injection), Qingweishi (Everolimus tablets), Saituo (Trastuzumab injection), Paletan (Pertuzumab injection), and Qingweiyi (Palbociclib capsules) [2]

Core Viewpoint - The International Electrotechnical Commission (IEC) has released two key international standards in the power semiconductor device sector, led by China, marking a significant breakthrough in China's participation in international standardization efforts for power semiconductor devices [1] Group 1: International Standards - The two revised international standards are "Semiconductor Devices - Part 2: Discrete Devices - Rectifier Diodes" (IEC60747-2:2025ED4.0) and "Semiconductor Devices - Part 6: Discrete Devices - Thyristors" (IEC60747-6:2025ED4.0) [1] - These standards address long-standing mismatches between technical content and product development, enhancing the applicability and operability of testing for high-power semiconductor devices [1] Group 2: Applications and Impact - Rectifier diodes and thyristors are fundamental semiconductor devices widely used in household appliances such as mobile phone chargers, lighting controls, vacuum cleaner speed regulation, and electromagnetic stove power control [1] - They are also extensively utilized in electric vehicles and charging stations, renewable energy generation, new power systems, smart grids, industrial automation, and aerospace [1] - The new standards will serve as important references for global manufacturers, users, and third-party testing organizations in product research, testing, and application, thereby improving the overall technology and quality level of China's power electronics industry [1] Group 3: Collaborative Efforts - Chinese experts, as project leaders, collaborated with specialists from Japan, Germany, and South Korea to discuss terminology, definitions, testing methods, and conditions within the standards [2] - The domestic technical team conducted over a thousand related experimental validations to ensure the standards are structurally rigorous and content-complete [2]

Core Insights - The 2025 AI+ Conference held in Beijing focused on the theme "AI Next Decade: Scene-Driven × New Quality Engine," highlighting the integration of AI in various industries [1] - Haibo Sichuang won the "AI 100 Application Benchmark" award for its "Intelligent Platform for the Full Lifecycle of Energy Storage Systems," showcasing a practical example of AI integration in the energy sector [1] Group 1: AI Integration in Energy Sector - The platform aims to achieve full-process intelligence in large-scale electrochemical energy storage plants by integrating AI, big data, and multi-agent optimization technology [1] - Key objectives of the platform include safety, efficiency, longevity, and high returns, supporting the digital and intelligent operation and decision-making of energy storage assets [1] Group 2: Operational Efficiency and Market Participation - The platform enhances operational efficiency of energy storage systems by 3%-5%, reduces auxiliary energy consumption by 15%-20%, and lowers operational costs by over 30% [2] - It enables energy storage systems to participate in multiple market self-scheduling, maximizing revenue through price prediction and interval optimization using deep learning and reinforcement learning [2] Group 3: Future Directions - Haibo Sichuang emphasizes that the future of AI lies not in chasing technological trends but in deeply rooting itself in industrial applications [2] - The company plans to continue leveraging intelligence as a driving force to innovate in the energy sector, promoting a safer, more efficient, and sustainable energy system [2]

据了解，华润万家本次大赛设置销售竞赛、"心服务"系列竞赛及"鲜锋技"系列竞赛等多个奖项，覆盖销 售、服务、生鲜加工等关键岗位，表彰了在各自领域展现高超专业技能的个人与团队。 中证报中证网讯（记者 王辉）近日，华润万家在深圳举行第二届"万家工匠"全国技能大赛总决赛颁奖 典礼，该赛事旨在选拔与表彰零售业务各环节高技能人才，弘扬工匠精神。 华润万家董事长徐健在本次活动上表示，技能人才是零售业务的核心基石，获奖者在平凡岗位上成就卓 越。他鼓励全体员工立足本职岗位持续精进业务能力，在常规工作中寻求突破。华润集团副总经理蓝屹 在寄语中肯定了一线员工的贡献，并强调技能人才是华润万家最宝贵的人才资源。未来，华润万家将持 续举办技能大赛、推进系统培训，不断树立技能人才标杆。 在本次活动上，华润万家正式发布了"大师傅"认证与发展机制，为技能人才规划清晰的职业发展路径。 同时，公司现场为十位顶尖匠人授予了"鲜锋工匠"专属奖章。为深化产教融合，华润万家还与中国东方 教育集团、王森教育集团签署了校企合作协议。 ...

Core Viewpoint - Shanghai Pharmaceuticals has received approval for its innovative drug, Sitojilun, aimed at treating primary hypertension, marking a significant achievement in its commitment to independent innovation in the pharmaceutical industry [1][2]. Group 1: Product Approval and Market Strategy - The innovative drug Sitojilun (SPH3127), a new generation oral non-peptide small molecule renin inhibitor, has been approved for market launch, addressing unmet clinical needs in hypertension treatment [1]. - Shanghai Pharmaceuticals has established a comprehensive distribution network covering over 80,000 medical institutions across 25 provinces, municipalities, and autonomous regions in China, ensuring effective market access for Sitojilun [1]. Group 2: Research and Development Investment - In 2024, Shanghai Pharmaceuticals plans to invest 2.818 billion yuan in R&D, positioning itself among the industry leaders in investment intensity [2]. - As of the end of Q3 2025, the company has submitted 57 new drug applications for clinical trials, with 45 of these being innovative drugs, demonstrating a robust pipeline and commitment to long-term innovation [2]. Group 3: Collaborative Innovation Ecosystem - The company has established the Shanghai Frontier Life Science Innovation Center to foster collaboration with top universities and research institutions, creating an open innovation ecosystem [3]. - Since its launch in September of last year, the center has attracted numerous renowned research institutions and pharmaceutical companies, enhancing the innovation landscape [3]. - Shanghai Pharmaceuticals aims to continue investing in R&D focused on urgent clinical needs in areas such as oncology, immunology, cardiovascular health, and infectious diseases, with the goal of transforming innovative results into marketable products [3].

陕西省委金融工委在通报中指出，开源证券等单位在征文组织过程中做到了"精心组织、严格审 核"，体现了公司对金融文化建设工作的高度重视。获奖征文以其扎实的理论基础、创新的实践探索和 显著的借鉴价值，获得了评审专家的一致认可。 本次征文活动经过严格评审，活动共评选出35篇优秀征文。其中，开源证券获奖作品系统阐释了在 陕西省委金融工委和陕煤集团党委的坚强领导下，公司创新运用"长宽高"立体工作法，将党的政治优势 有效转化为企业发展优势的实践路径，为推动中国特色金融文化建设提供了具有参考价值的"开源样 本"，彰显了公司以党建引领高质量发展的责任担当与创新活力。 下一步，开源证券将深入学习贯彻党的二十届四中全会精神，持续深学细悟中国特色金融文化核心 要义，坚持党建引领，锚定主责主业，深刻把握金融工作的政治性、人民性，以文化"软实力"赋能企业 核心竞争力，以科技金融为牵引统筹做好"五篇大文章"，为奋力谱写中国式现代化建设的陕西新篇章贡 献开源力量。 中证报中证网讯（记者 何昱璞）近日，中共陕西省委金融工作委员会公布了"弘扬中国特色金融文 化 谱写陕西金融时代新篇"主题征文活动评选结果。开源证券凭借出色的组织工作和高质量的征文 ...

Group 1 - The core point of the news is that CapitaLand Investment has successfully raised its second domestic sub-fund under its RMB mother fund platform, reaching a total scale of 1 billion RMB, which is expected to increase its asset management scale by approximately 1.48 billion RMB [1] - The newly raised fund, China Retail RMB Fund (CRF I), has attracted multiple local institutional investors in addition to the capital commitment from the mother fund [1] - Since 2021, CapitaLand Investment has established nine onshore RMB funds, accumulating nearly 55 billion RMB in domestic fundraising [1] Group 2 - CapitaLand Investment's first sub-fund under the RMB mother fund, China Industrial Park Fund IV, completed fundraising in September 2025 with an asset management scale of 1.74 billion RMB, using the Dalian Tengfei Park project as a seed asset [2] - The company has a rich asset reserve in first-tier and strong second-tier cities, including shopping centers, industrial parks, logistics parks, and rental housing, which supports the establishment of more sub-funds in the future [2] - The CapitaLand Mall New Central project in Qingdao, with a total construction area of 141,000 square meters and an occupancy rate of approximately 99.6%, will be restructured into the capital structure of CRF I as a seed asset [1]

12月11日，中汽协副秘书长陈士华在月度信息发布会上表示，11月，汽车产销延续良好表现。企业抢抓 政策窗口期，生产供给依然保持较快节奏。其中，乘用车市场运行平稳，商用车市场持续向好，新能源 汽车表现强劲，汽车出口较快增长。 具体来看：11月，汽车产销分别完成353.2万辆和342.9万辆，同比分别增长2.8%和3.4%。月度产量首次 超过350万辆，创历史新高。 新能源汽车方面，今年前11个月，我国新能源汽车产销量均接近1500万辆，同比增长均超过30%；出口 方面，新能源汽车出口231.5万辆，同比增长1倍。 1—11月，汽车产销分别完成3123.1万辆和3112.7万辆，同比分别增长11.9%和11.4%。 ...

Core Viewpoint - The report highlights the successful transformation of the Shijiazhuang project under Zhongke Environmental Protection, showcasing its shift from operational losses to significant economic benefits through efficient green energy utilization and technological innovation [1][2]. Group 1: Project Transformation - The Shijiazhuang project was acquired by Zhongke Environmental Protection at the end of 2023, and through years of operational experience and technological innovation, the thermal energy utilization efficiency was improved from 25% to 60% [1]. - The project achieved a turnaround from "insufficient capacity" to "full-load operation" and from "operational losses" to "significant benefits" within one year, resulting in an economic benefit increase of over 50 million yuan in its first year post-acquisition [1]. Group 2: Technological Empowerment - Zhongke invested over 40 million yuan in technological upgrades, implementing more than ten projects including flue gas waste heat utilization and intelligent heating systems, which contributed to an annual economic benefit increase of over 17 million yuan [2]. - The project exemplifies a replicable model for industry transformation, moving from loss to profitability and achieving ultra-low emissions through "technology leadership and model innovation" [2]. Group 3: Future Development and Goals - Zhongke Environmental Protection aims to continue promoting the transformation of advanced technological achievements from research institutions and universities to enhance energy utilization efficiency and resource levels [2]. - The company is committed to a high-quality sustainable development path driven by innovation, collaboration, and open empowerment within the industry [2].

"中国互联网金融协会"微信公众号12月11日消息，为落实《关于规范供应链金融业务引导供应链信息服 务机构更好服务中小企业融资有关事宜的通知》要求，切实做好账款凭证业务自律管理工作，中国互联 网金融协会在北京组织召开供应链金融业务会员座谈会。 中国互联网金融协会秘书长马超表示，协会按照《通知》要求积极推进自律管理各项工作，目前基本实 现对账款凭证主要从业机构的自律管理触达，初步建立业务统计监测机制，基本摸清市场底数，持续宣 贯先规范再发展的指导思想，助推凭证期限合理控制、融资成本持续下行，引导弱小平台有序退出，及 时处理相关风险事件。一是合规整改仍是当前的首要任务，绝不能"带病"盲目扩张发展；二是协会会员 单位要成为优等生，发挥模范带头作用，尽快完成合规整改、申请备案；三是协会将以自律备案为抓 手，用好自律检查、惩戒等手段，让合规者受益、违规者出局，逐步推动行业优胜劣汰。 ...